INS and type 2 diabetes mellitus: Disruption of the IRS/PI3K pathway leads to decreased tissue sensitivity to the metabolic action of insulin - a state of insulin resistance (IR), which is characteristic of patients with type 2 diabetes (T2D), obesity and arterial hypertension (6, 7).